MINRAD International (BUF) Announces Japanese Approval of Sevoflurane
MINRAD International (AMEX: BUF) announced that its exclusive distribution partner in Japan, Merck Seiyaku, has received approval of Sevoflurane from the Japanese Ministry of Health. Prior to sale of Sevoflurane in Japan, Merck Seiyaku will need to receive pricing authorization from the Japanese Government, which it expects in July of 2007.
MINRAD International, Inc. is an interventional pain management company with real-time image guidance and anesthesia and analgesia product lines.
MINRAD International, Inc. is an interventional pain management company with real-time image guidance and anesthesia and analgesia product lines.
You May Also Be Interested In
- Vertex Pharmaceuticals (VRTX) Gets Positive Opinion from CHMP for KALYDECO
- Cytokinetics (CYTK) Opens Second Cohort for ATOMIC-AHF Phase IIb
- MediciNova (MNOV) Says Results of Phase 2B Trial of MN-221 Didn't Meet Primary Endpoint; to Move Forward with End of Phase Meeting
Create E-mail Alert Related Categories
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
